Navigation Links


Vitreoretinal in Medical News

Appeal Proceedings on European VisionBlue Patent Stayed; Patent Remains in Force

...tion in 1983, D.O.R.C. has developed into a market leader in research, development and production of products for eye surgery, especially products for vitreoretinal and cataract surgery. Our products are used by eye surgeons worldwide, because of the high quality development and because our products are known for ...

Eye Disease, Cognitive Decline Linked in Study

...ssor, department of ophthalmology, Centre for Eye Research Australia, The University of Melbourne, Victoria, Australia; Demetrios Vavvas, M.D., Ph.D., vitreoretinal surgeon, Massachusetts Eye and Ear Infirmary, Boston, and principal investigator, angiogenesis laboratory, Harvard Medical School, Boston; May 2009 ...

Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors

...The presentation will feature James M. Maisel M.D. and Joanna J. Oda, M.D., vitreoretinal specialists from the Retina Group of New York. As people live longer, they...etina Group of New York The Retina Group of New York has provided tertiary vitreoretinal care to patients in Nassau and Suffolk Counties since 1986 at its offices i...

Crystalens HD(TM) Receives FDA Approval

...any has one of the oldest, best known and most respected healthcare brands in the world. Bausch & Lomb offers a full suite of products in cataract and vitreoretinal surgery including intraocular lenses and delivery systems, phacomulsification equipment and other surgical instruments and devices. To learn more abou...

Barry G. Caldwell Named Chief Executive Officer of STAAR Surgical

...sible for managing all functional areas including surgical instrumentation, intraocular lenses and disposable devices used in cataract, refractive and vitreoretinal procedures. Prior to Alcon's acquisition of CooperVision in 1989, Mr. Caldwell served in several leadership positions with CooperVision and Cavitron...

Gene therapy safety trial for childhood blindness under way

...al. Byrne is the principal investigator at UF. The actual medical technique used to transfer the gene is not unusual, said Kaushal, who directs the vitreoretinal service in the UF College of Medicine. The procedure involves two incisions that give the surgeon access to the surface of the retina, Kaushal said...

Digital Healthcare Announces Appointment of Dr. Suber Huang as Medical Director

...Vice Chairman in the Department of Ophthalmology and Visual Sciences, University Hospitals Case Medical Center, Cleveland, Ohio. He is the Director of vitreoretinal Diseases and Surgery, the Director of Clinical Research, and the Director of the Retinal Diseases Image Analysis Reading Center (REDIARC). Dr. Huang s...

Results for Wet Age-Related Macular Degeneration Show Significant Vision Improvements

...s a major cause of central visual loss and is one of the leading causes of blindness in people over 60. Dr. David M. Brown, retinal surgeon with vitreoretinal Consultants at The Methodist Hospital, is lead author on the ANCHOR study and a secondary author on the MARINA study. Brown enrolled more patients tha...

Radiation therapy effective against Eye cancer

... Kathryn Greven, Radiation oncologist and Craig Greven, vitreoretinal surgeon, Wake Forest University have been treating patients with malignant melanoma of uvea with radiation therapy. Uveal malignant melanoma// is a ra...
Vitreoretinal in Medical Technology

ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402

...pment for the non-surgical treatment of back of the eye diseases. Microplasmin is also being evaluated in Phase II clinical development for additional vitreoretinal indications and as a potential therapy for stroke. ThromboGenics is also developing novel antibody therapeutics in collaboration with BioInvent Intern...

ThromboGenics' Microplasmin Phase III Program Progressing According to Schedule

...pment for the non-surgical treatment of back of the eye diseases. Microplasmin is also being evaluated in Phase II clinical development for additional vitreoretinal indications and as a potential therapy for stroke. ThromboGenics is also developing novel antibody therapeutics in collaboration with BioInvent Intern...

ThromboGenics Completes Patient Enrolment for Phase II Trial of Microplasmin for the Treatment of Diabetic Macular Edema (MIVI II DME)

...pment for the non-surgical treatment of back of the eye diseases. Microplasmin is also being evaluated in Phase II clinical development for additional vitreoretinal indications and as a potential therapy for stroke. ThromboGenics is also developing novel antibody therapeutics in collaboration with BioInvent Intern...

ThromboGenics and BioInvent Receive Technology Transfer Success Fee From Roche for the Novel Anti-Cancer Antibody, TB-403 (Anti-PIGF)

...pment for the non-surgical treatment of back of the eye diseases. Microplasmin is also being evaluated in Phase II clinical development for additional vitreoretinal indications and as a potential therapy for stroke. ThromboGenics is also developing novel antibody therapeutics in collaboration with BioInvent Intern...

ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease

...pment for the non-surgical treatment of back of the eye diseases. Microplasmin is also being evaluated in Phase II clinical development for additional vitreoretinal indications and as a potential therapy for stroke. ThromboGenics is also developing novel antibody therapeutics in collaboration with BioInvent Intern...

ThromboGenics Announces Promising Results of MITI IV Phase II Trial in the Treatment of Acute Stroke with Microplasmin

...ease and cancer. The Company has several programs in Phase II clinical development including microplasmin, which is being evaluated as a treatment for vitreoretinal disorders and as a thrombolytic agent for vascular occlusive diseases. ThromboGenics is also developing novel antibody therapeutics in collaboration w...

MacuSight(TM) Announces Positive Preliminary Results From Phase 1 Study of Sirolimus in Wet Age-Related Macular Degeneration

...in U. Dugel, M.D., member of MacuSight's scientific advisory board, managing partner, Retinal Consultants of Arizona, Phoenix AZ, clinical instructor, vitreoretinal diseases and surgery, department of ophthalmology, University of Arizona, and the study's lead investigator. As part of the design of this randomize...

MacuSight(TM) Announces Positive Initial Results From Phase 1 Study of Sirolimus in Diabetic Macular Edema

...biological activity of sirolimus administered through subconjunctival injection are very exciting," stated Pravin U. Dugel, M.D., clinical instructor, vitreoretinal diseases and surgery, department of ophthalmology, University of Arizona, partner at Retinal Consultants of Arizona in Phoenix, Arizona, and the study...
Vitreoretinal in Medical Products

Micro Vitreoretinal Cannula Angled

Description: Micro Vitreoretinal Cannula; Angled; 20g (0.90) x 1" (25mm); Tip Extension: 3mm, 32g (0.23); Angled at 65°, 1mm from Tip....
Company:Oasis Medical

BD Visitec Vitreoretinal Cannulas

Description: Cannula: .90mm x 28mm (20 G x 1 1/8 in) Handle: 9.3cm (3 5/8 in) long, Flute, .90 x 28mm, vacuum handle [Charles]...
Company:BD Ophthalmics

clariVit Central Mag.

Description:... This patented lens offers high resolution by far surpassing any medium magnification vitreoretinal surgical lens in stereopsis, brilliance and clarity, detailed visualization to the equatorial regions, vitrectomy in diabetics, membrane peeling exten...
Company:Volk Optical, Inc.

Surgical Viewing System

Description:...e most technologically advanced wide angle viewing system available for the vitreoretinal surgeon. Its unique single-element prism design, numerous advanced features...e-field viewing capability have made it the #1 panoramic viewing system for vitreoretinal surgery since its introduction....
Company:Volk Optical, Inc.

Mini Quad® XL

Description:... MiniQuad XL is recommended for evaluating vitreoretinal relationships of the entire fundus and in the management of dislocated lenses. It is the ideal lens for small pupil fundus viewing with the operating ...
Company:Volk Optical, Inc.

PeaceKeeper Extrusion Aspiration Cannula Eraser Instrument

Description:...sis with extrusion aspiration and backflush functionality in a single use, sterile instrument, the PeaceKeeper delivers exceptional value, utility and vitreoretinal surgical performance....
Company:Medtronic Ophthalmics

Eftiar Octane

Description:... Eftiar offers the vitreoretinal surgeon a temporary tamponade for efficient re-attachment of the retina, release of subretinal fluid, dissection of fibro-vascular proliferation and c...
Company:Dutch Ophthalmic, USA

Perfluoron Liquid

Description:... Welcome to a new dimension in vitreoretinal surgery. By using Perfluoron, a liquid tool composed of purified perfluoro-n-octane, you can greatly expand your surgical capabilities. Perfluoron ...
Company:Alcon Laboratories

Hexon Illumination System - 1266 XII

Description:...amp, a more efficient source of high quality illumination. This exceptional illumination quality provides a color consistency which is well suited for vitreoretinal surgery. D.O.R.C. has also responded to clinical concerns regarding minimizing the incidence of phototoxicity, especially when surgical conditions dic...
Company:Dutch Ophthalmic, USA

Harmony Special Peristaltic IV

Description:...ctions. The Harmony Special Peristaltic is designed to meet the needs of any practice setting with the possibility to add special options for advanced vitreoretinal surgery....
Company:Dutch Ophthalmic, USA

More>>

Vitreoretinal in Medical Dictionary

Detached retina

...d about causes, symptoms and treatment of a detached retina , which requires prompt action to prevent permanent vision loss. Vitrectomy and vitreoretinal eye surgery can help treat retinal detachments ... Detached retina . Diabetic retinopathy. Diabetic retinopathy - eye doctor Q&A ... ...
Vitreoretinal in Biological Technology

ThromboGenics NV: Business Update

...pment for the non-surgical treatment of back of the eye diseases. Microplasmin is also being evaluated in Phase II clinical development for additional vitreoretinal indications and as a potential therapy for stroke. ThromboGenics is also developing novel antibody therapeutics in collaboration with BioInvent Intern...

ThromboGenics Announces Business Update and 2008 Full Year Results

...pment for the non-surgical treatment of back of the eye diseases. Microplasmin is also being evaluated in Phase II clinical development for additional vitreoretinal indications and as a potential therapy for stroke. ThromboGenics is also developing novel antibody therapeutics in collaboration with BioInvent Intern...

ThromboGenics and BioInvent Start Phase II Trial of TB-402, a Novel, Long Acting Anticoagulant for Deep Vein Thrombosis (DVT) Prophylaxis

...pment for the non-surgical treatment of back of the eye diseases. Microplasmin is also being evaluated in Phase II clinical development for additional vitreoretinal indications and as a potential therapy for stroke. ThromboGenics is also developing novel antibody therapeutics in collaboration with BioInvent Intern...

Alimera Sciences Begins Pilot Study to Assess Safety and Efficacy of Iluvien(TM) in Patients With Bilateral Geographic Atrophy Due to AMD

... occurs in these animals," said Raymond Iezzi, M.D., M.S., Scientific Director, Ligon Research Center of Vision, Assistant Professor of Ophthalmology, vitreoretinal Service, Kresge Eye Institute, Wayne State University School of Medicine. "These results were considered compelling enough to warrant a huma...

ThromboGenics N.V.: Business Update

...ease and cancer. The Company has several programs in Phase II clinical development including microplasmin, which is being evaluated as a treatment for vitreoretinal disorders and as a thrombolytic agent in stroke. ThromboGenics is also developing novel antibody therapeutics in collaboration with BioInvent Internat...

ThromboGenics Announces Half Year Results 2008

...ease and cancer. The Company has several programs in Phase II clinical development including microplasmin, which is being evaluated as a treatment for vitreoretinal disorders and as a thrombolytic agent for vascular occlusive diseases. ThromboGenics is also developing novel antibody therapeutics in collaboration w...

ThromboGenics Appoints Dr. Patrik De Haes as Chief Executive Officer

...ease and cancer. The Company has several programs in Phase II clinical development including microplasmin, which is being evaluated as a treatment for vitreoretinal disorders and as a thrombolytic agent for vascular occlusive diseases. ThromboGenics is also developing novel antibody therapeutics in collaboration w...

ThromboGenics Presents Results of the Phase I Trial of TB-402 at the Prestigious American Society of Hematology Annual Meeting

...nd eye diseases. The Company has several programs in Phase II clinical development including microplasmin, which is being evaluated as a treatment for vitreoretinal disorders and as a thrombolytic agent for vascular occlusive diseases, including acute stroke. ThromboGenics is also developing novel antibody therape...

ThromboGenics Presents Results of the Vitreomacular Traction Trial (MIVI IIT) at the American Society of Retina Specialists Annual Meeting

...nd eye diseases. The Company has several programs in Phase II clinical development including microplasmin, which is being evaluated as a treatment for vitreoretinal disorders and as a thrombolytic agent for vascular occlusive diseases, including acute stroke. ThromboGenics is also developing novel antibody therape...
Vitreoretinal in Biological Dictionary

Retina

...ll retinal disorders including macular degeneration, macular hole and pucker, diabetic retinopathy, and retinal detachment. Specialists in treating vitreoretinal disease, macular degeneration, and diabetic retinopathy. ...
Other TagsFell
(Date:12/2/2009)...ilies around the world will join together for the ...ng Sunday, December 13 to remember all children wh...ll be held in the United States and around the glo...ss candle lighting. , Oak...sands of families around the world, grieving the l...
(Date:12/2/2009)...the New Year traditionally inspires making resolut...care. What to do to ensure the energy, and positiv...010? It’s easy; make self-care the #1 prior...y mission. It isn,t any wonder their products exce...ide to safe cosmetic products. , ...
(Date:12/2/2009)...l Products Inc., an industry leader in healthcare ...s the opening of its new headquarters in the Irvin...search Drive, Irvine, California 92618. In additio... Irvine Spectrum plus an assembly and distribution...expansion reflects Links Medical,s rapid growth an...
(Date:12/2/2009)...com Enables Personal Health Record Devices with Me...gton, PA (PRWEB) December 2, 2009 -- Perhaps the b...eir own medical records. With the advent of Person... medical records is easier than ever. MyEMRChoice....logy company has added services that will populate...
(Date:12/2/2009)...s Achieves IBM Ready for LINUX designation and enh...he mainframe and contemporary systems running Linu...December 2, 2009 -- eCube Systems, a leader in leg... announced that it has achieved the IBM Ready for ...middleware. This mark certifies NXTera has met co...
Breaking Medicine News(10 mins):Health News:Bereaved Families Unite for Compassionate Friends Worldwide Candle Lighting 2Health News:The New Year's Resolution that Fuels Them All: Self-Care; Garden of Eve Makes Self-Care Through Safe Skin Care # 1 Priority 2Health News:The New Year's Resolution that Fuels Them All: Self-Care; Garden of Eve Makes Self-Care Through Safe Skin Care # 1 Priority 3Health News:The New Year's Resolution that Fuels Them All: Self-Care; Garden of Eve Makes Self-Care Through Safe Skin Care # 1 Priority 4Health News:Links Medical Opens New Headquarters, Prepares to Launch Medical-Grade Manuka Honey 2Health News:Links Medical Opens New Headquarters, Prepares to Launch Medical-Grade Manuka Honey 3Health News:Personal Health Records On-Demand, In Your Pocket 2Health News:eCube Delivers Linux on System z Support for NXTera High Performance Middleware 2Health News:eCube Delivers Linux on System z Support for NXTera High Performance Middleware 3
(Date:12/2/2009)...alamanca and another from Yale University have sho...viour of Acanthodactylus beershebensis , a lizard...ccording to the study, these reptiles move less an... under pressure from predators. , Many theoretic... there had been very few experimental trials and n...
(Date:12/1/2009)...mate Research Center, Emory University, have succe...es, an important step toward unlocking the genetic...of this technology will enable scientists to perfo...identify the brain mechanisms of social bonding an... may also have important implications for understa...
(Date:12/1/2009).... , Brown adipose tissue is different from whi...iniature power stations which among other things c...te a voltage similar to that of a battery, which t...r, the mitochondria of brown fat cells have a shor...The energy released when the fat is broken down is...
Breaking Biology News(10 mins):Lizards change their diet to avoid predators 2Yerkes researchers create first transgenic prairie voles 2Brown fat cells make 'spare tires' shrink 2Medical Food Reduces Medical Costs and Use of Anticonvulsant Medication When Treating Diabetic Neuropathy According to HealthCore Study Presented at 5722 1Medical Food Reduces Medical Costs and Use of Anticonvulsant Medication When Treating Diabetic Neuropathy According to HealthCore Study Presented at 5722 2Medical Food Reduces Medical Costs and Use of Anticonvulsant Medication When Treating Diabetic Neuropathy According to HealthCore Study Presented at 5722 3UT Southwestern patient first in North Texas to receive newest generation heart failure device 10532 1UT Southwestern patient first in North Texas to receive newest generation heart failure device 10532 2UT Southwestern patient first in North Texas to receive newest generation heart failure device 10532 3Break through Preventative Care Program for People Living With Bipolar Disorder 5721 1Break through Preventative Care Program for People Living With Bipolar Disorder 5721 2
Other Contentspituitarypituitarypituitarypituitarypituitarypituitarypituitaryplacentaplacentaplacentaplacentamammalsmammalsmammalsmammalsmammalsmammalsplacentalplacentalplacentalplacentalplacentalplaqueplaqueplaqueplaqueplaqueplaqueplaqueplaqueplastid